Building Resilience and Agility in the Pharma Supply Chain
On demand webinar recording - now available
Fill the details to view the Webinar
Supply disruptions due to Covid-19 and raw material shortages have significantly impacted pharmaceutical organizations. Increasing demands and limitations in logistics and courier services further tested the supply chains. With new challenges and various environmental factors coming into place, pharmaceutical organizations have embarked on adopting digital analytics , new collaborations with government agencies , focus on sustainable supply chain, and changing the organization's internal structure for focused decision making.
In this webinar, we will take a closer look on the API supply chain and real live case studies on how to predict the impact of disruptions and achieve sustainability targets.
What you will learn:
#1 Global supply chain intelligence and how to - predict the impact of disruptions
#2 Integrated business planning
#3 Sustainable supply chains: Reducing the carbon footprint in - the supply chains
#4 Managing Covid-19 induced disruptions and robust business continuity plans
Speakers
Dr. Ravi Prakash Mathur
Vice President and Global Head of Logistics and Supply Chain Excellence Dr. Reddy’s Laboratories Ltd.
Summary of the Webinar
In this webinar, Dr. Ravi Prakash Mathur, Vice President and Global Head of Logistics and Supply Chain Excellence, Dr. Reddy's Laboratories Ltd, addresses - the API supply chain challenges and supply chain management in the pharmaceutical industry complemented with live case studies on how to predict the impact of supply disruptions and achieve sustainability targets.
The first section of the webinar provides insights on sustainability pharmaceutical supply chain focusing on reducing the carbon footprint in the supply chains and logistics and Dr. Reddy's journey in sustainability so far, covering aspects of product responsibility, transparency, operational excellence, and human dignity, equal opportunity, and community development.
The following section covers - managing COVID-19 induced disruptions and business continuity planning and interventions in response to the pandemic and supply chain management in pharmaceutical industry. The role of collaboration in managing disruptions – Strong partner network, cross-industry collaboration groups and opening to new possibilities, leveraging data for LDM & reviewing operations, slicing, and dicing of data for identifying levers for LDM and third-party risk management for sourcing.
The next section of the webinar gives information on digital transformation, integrated business planning (IBP) - project O2: one team, one plan vision, and key objectives, IBP platform features, framework, cross-functional processes, and change management steps. The final session covers – global supply chain intelligence, predicting the impact of disruptions, market intelligence, and critical benefits of procurement dashboards.
Pharmaceutical supply chain management have become complex and become prone to disruptions. As a result, there is a need to keep an eye on and be aware of emerging external scenarios and assess their impact on customer product availability. Supply uncertainty also impacts organizational performance and must synchronize the business processes to create visibility of various performance indicators in advance.
Are you interested in learning more about our global supply chain intelligence, pharmaceutical supply chain, integrated business plan, carbon footprint, managing COVID-19 induced disruptions, and robust business continuity plans? Then contact us at [email protected]
如果您有任何特定国家的需求，我们乐意提供帮助。
免责声明
本網站上的任何信息，包括對任何產品或服務的任何提及，均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是，在某些情況下，雷迪博士可自行決定並根據當地法律要求，在存在此類監管豁免的任何地方，提供此類產品的研究數量，以根據《印度專利法》第 107A 條（Bolar 豁免）進行監管提交。購買者應對其各自市場的產品或服務（包括專利情況）進行獨立評估，並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證，包括但不限於適銷性、適用於特定用途和非侵權的保證。